| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Desipramine hydrochloride 100 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Desipramine hydrochloride 150 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Grepafloxacin 400 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely grepafloxacin 600 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guanadrel sulfate 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydroflumethiazide 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely delavirdine mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guanabenz acetate 4 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Estazolam 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Estazolam 2 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fenofibrate 160 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guanethidine monosulfate 25 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| erythromycinethylsuccinat 400 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Glibenclamide micronised 1.5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Glibenclamide micronised 4.5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Glibenclamide 6.3 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Colesevelam hydrochloride 625 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 25 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guaifenesin 1 g oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guaifenesin 675 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guaifenesin 575 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Disulfiram 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guaifenesin 200 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Griseofulvin ultramicrosize 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Dexchlorpheniramine maleate 2 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Griseofulvin microsize 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diclofenamide 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydrocodone bitartrate 7.5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Estradiol 500 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Etacrynic acid 25 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Finasteride 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely etacrynic acid 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Dexamethasone 4 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fosinopril sodium 40 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Didanosine 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cortisone acetate 5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fexofenadine hydrochloride 60 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diltiazem hydrochloride 30 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diltiazem hydrochloride 60 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diltiazem hydrochloride 90 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diltiazem hydrochloride 120 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Flecainide acetate 150 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cimetidine 300 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely diltiazem maleate 120 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely diltiazem maleate 180 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely diltiazem maleate 240 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diiodohydroxyquinoline 210 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cyclobenzaprine hydrochloride 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Etidronate disodium 400 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guaifenesin 600 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| flavoxat 100 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Guanabenz acetate 8 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Choline bitartrate 25 mg and dexpanthenol 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Choline bitartrate 25 mg and dexpanthenol 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| dehydrocholsyre 180 mg + dimethicon 40 mg + pancreatin 300 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| dehydrocholsyre 180 mg + dimethicon 40 mg + pancreatin 300 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| dehydrocholsyre 180 mg + dimethicon 40 mg + pancreatin 300 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
3 |
| Deserpidine 250 microgram and methyclothiazide 5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Deserpidine 250 microgram and methyclothiazide 5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| desogestrel 0,15 mg + ethynylestradiol 0,03 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| desogestrel 0,15 mg + ethynylestradiol 0,03 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Diltiazem maleate 219 mg and enalapril maleate 5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diltiazem maleate 219 mg and enalapril maleate 5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Diprophylline 100 mg and guaifenesin 100 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diprophylline 100 mg and guaifenesin 100 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| enalaprilmaleat 10 mg + hydrochlorthiazid 25 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| enalaprilmaleat 10 mg + hydrochlorthiazid 25 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| enalaprilmaleat 5 mg + hydrochlorthiazid 12,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| enalaprilmaleat 5 mg + hydrochlorthiazid 12,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Ethinylestradiol 35 microgram and etynodiol diacetate 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ethinylestradiol 35 microgram and etynodiol diacetate 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Ethinylestradiol 50 microgram and etynodiol diacetate 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ethinylestradiol 50 microgram and etynodiol diacetate 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
3 |
| Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| ethynylestradiol 0,05 mg + levonorgestrel 0,25 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| ethynylestradiol 0,05 mg + levonorgestrel 0,25 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
FHIR